ArticleFrontiers in oncology2025

Cytokine profiling identifies circulating IL-2, IL23 and sPD-L1 as prognostic biomarkers for treatment outcomes in non-small cell lung cancer patients undergoing anti-PD1 therapy.

Kriti Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.